1st Annual Dr. Douglas H. Kay Continuing Pharmacy Education Symposium

“Students, our faculty are here, not so much to lead you, but to help you discover your talents and skills as independent learners and student pharmacists”. 1st Annual Dr. Douglas H. Kay Continuing Pharmacy Education Symposium Friday July 27th, 2012 University of New England College of Pharmacy Hannaford Lecture Hall 716 Stevens Avenue Portland, Maine 04103 University of New England College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of Continuing Pharmacy Education. 8:00am Registration/ continental Breakfast 8:30am: “Healthcare Litigation: An Interprofessional Approach to Reducing Medical Errors.” Curt R. Cyr, Ph.D., R.Ph. – UNE-COP - Associate Professor of Pharmaceutical Sciences 1 contact hour CPE Objectives: Recognize the costs, both human and financial, of medical errors; Define liability and malpractice; Identify problems in the delivery of healthcare especially the transition of care from one environment to another; Describe methods to decrease medical errors by improving interprofessional communication and medical records; Identify at least two classes of medication that may cause harm and result in healthcare litigation even if they are used within the established guidelines. ACPE #0837-0000-12-041-L01-P and #0837-0000-12-041-L01-T 9:30am: Chemotherapy-Induced Febrile Neutropenia: Prevention and Treatment Edward Li, PharmD, BCOP - Associate Professor – UNE-COP Department of Pharmacy Practice 1 contact hour CPE Objectives: Describe patient-and-regimen-specific risk factors for developing febrile neutropenia after receiving chemotherapy; Discuss the appropriate use of myeloid growth factors for the primary and secondary prophylaxis of febrile neutropenia in patients receiving myelosuppressive chemotherapy; Recognize appropriate therapies for the empiric treatment of febrile neutropenia. ACPE #0837-0000-12-039-L01-P and #0837-0000-12-039-L01-T 10:30am Break/ Refreshment 11am: MRSA- Methicillin-Resistant Staphylococcus aureus George P. Allen, Pharm.D.,Associate Professor – UNE-COP Department of Pharmacy Practice 1 contact hour CPE Objectives: Describe the epidemiology and clinical implications of infections caused by methicillin-resistant Staphylococcus aureus (MRSA); Review mechanisms of resistance associated with MRSA; Explain differences in the management of infections caused by community-associated and healthcare-associated MRSA infections; Differentiate available antimicrobial therapies for MRSA based on pharmacology adverse events, and clinical evidence; Develop strategies that will prevent transmission of MRSA. ACPE #0837-0000-12-040-L01-P and #0837-0000-12-041-L01-T Noon: Lunch—DHK Retrospective—Dean Gayle Brazeau 1pm: Medication Therapy Management: “Build it and they will come” Meghan Sullivan, PharmD - Assistant Professor, Department of Pharmacy Practice – 1 contact hour Objectives: Discuss the history of Medication therapy Management (MTM): where we have been, and where we are going; Describe the various core components of MTM, including; medication therapy review (MTR), personal medication record (PMR), medication action plan (MAP), intervention and/ or referral, documentation and follow-up; Discuss the current marketplace for MTM services; Discuss the design, development, implementation, sustainability and measures for continuous quality improvement revolving around MTM services; Evaluate current, and discuss future, reimbursement strategies for MTM services. ACPE #0837-0000-12-037-L01-P and #0837-0000-12-037-L01-T 2pm: Medication Errors: Lessons Learned Lisa Pagnucco, BSPharm, PharmD, BCACP - Assistant Professor, Department of Pharmacy Practice - 1 contact hour Objectives: Describe how awareness of the prevalence and extent of medication errors has led to changes in health care delivery; Identify where most errors commonly occur in the medication process; Discuss strategies being implemented to reduce the occurrence of medication errors ACPE #0837-0000-12-042-L05-P and #0837-0000-12-042-L05-T 3pm: Break/ Refreshments 3:15pm: Pharmacogenomics Daniel Brazeau, Ph.D. - Research Associate Professor, College of Pharmacy - 1 contact hour Objectives: Explain basic genetic concepts as they pertain to drugs and drug therapy. Specifically, a) What genes are and how they contribute to human variability to disease and drug response. b) How variants on genes encoding metabolizing enzymes, transporters and receptors affect drug efficacy and toxicity; Describe to patients and colleagues what pharmacogenomics is and how it will impact pharmaceutical care in oncology? Specifically, a) the molecular genetic technologies employed in drug discovery and development of biomarkers for drug effect and drug safety. b) How human genetic variation contributes to differences in tumor biology, drug metabolish, toxicity, and therapeutic response. ACPE #0837-0000-12-038-L01-P and #0837-0000-12-038-L01-T Requirements for Receiving CE Credit: • Successful completion of post-presentation questions • Participation at live program • Complete program evaluation form REGISTRATION: Participants are encouraged to register before the CE program by contacting Pauline Dombrowik. pdombrowik@une.edu 207-221-4161 Registration Fee: $50.00 per person Checks are payable to UNE and due when signing in on presentation night, or mailed to UNE College of Pharmacy, 716 Stevens Ave. Portland, Maine 04103 Attn: Pauline Dombrowik 6 Contact Hours-Continuing Pharmacy Education